MIR548AK

Across TCGA pan-cancer cohorts, MIR548AK RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated MIR548AK data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR548AK RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR548AK expression acts as an unfavorable survival marker.

LUAD, THCA, and KIRC are the cancer types where MIR548AK RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	II,III,IV	0.284	0.734	<.001	90	view →
THCA	OS	Tertile	IV	0.579	0.986	<.001	51	view →
KIRC	OS	Tertile	All	0.703	0.812	.013	36	view →
COAD	OS	Tertile	IV	0.039	0.660	<.001	36	view →
SKCM	OS	Tertile	IV	0.179	0.727	<.001	36	view →
LUSC	OS	Tertile	III,IV	0.209	0.708	<.001	36	view →
BLCA	DFS	Tertile	All	0.255	0.600	.029	18	view →
DLBC	DFS	Tertile	All	0.107	0.634	.018	18	view →
STAD	DFS	Tertile	All	0.569	0.741	.025	18	view →
PAAD	OS	Tertile	All	0.132	0.590	<.001	18	view →
MESO	DFS	Tertile	III,IV	0.078	0.376	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

MIR548AK–LUAD (DFS)

Open the LUAD breakdown →